An Algorithm for the Operational Assessment of Adverse Drug Reactions: I. Background, Description, and Instructions for Use

JAMA: The Journal of the American Medical Association

Volumn 242, Issue 7, 1979, Pages 623-632

  Kramer, Michael S ^a   Leventhal, John M ^a   Hutchinson, Tom A ^a   Feinstein, Alvan R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHLORAMPHENICOL; CYCLOPHOSPHAMIDE; DIGOXIN; ERYTHROMYCIN; PENICILLIN G; PENICILLIN V; PHENYTOIN;

ADVERSE DRUG REACTION; ALGORITHM; CLASSIFICATION; DIAGNOSIS; EPIDEMIOLOGY;

DECISION MAKING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY; DRUG THERAPY, COMBINATION; HUMAN; OPERATIONS RESEARCH; PHARMACEUTICAL PREPARATIONS; SUPPORT, U.S. GOV'T, NON-P.H.S.; TOXICOLOGY;

EID: 0018645590     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1979.03300070019017     Document Type: Article

References (22)

1. Schimmel EM: The hazards of hospitalization. Ann Intern Med 60:100-110, 1964.
2. Seidl LG, Thornton GF, Cluff LE: Epidemiological studies of adverse drug reactions. Am J Public Health 55:1170-1175, 1965.
3. Hurwitz N, Wade OL: Intensive hospital monitoring of adverse reactions to drugs. Br Med J 1:531-536, 1969.
4. Miller RR: Drug surveillance utilizing epidemiological methods: A report from the Boston Collaborative Drug Surveillance Program. Am J Hasp Pharm 30:584-592, 1973.
5. Kellaway GSM, McCrae E: Intensive monitoring for adverse drug effects in patients discharged from acute medical wards. NZ Med J 78:525-528, 1973.
6. Apriet A, Apriet C, Larousse C, et al: Methodology and results of a survey of adverse reactions to a drug in private practice. Eur J Clin Pharmacol 11:181-192, 1977.
7. Caranasos GJ, Stewart RB, Cluff LE: Druginduced illness leading to hospitalization. JAMA 228:713-717, 1974.
8. Miller RR: Hospital admissions due to adverse drug reactions: A report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med 134:219-223, 1974.
9. Porter J, Jick H; Drug-related deaths among medical inpatients. JAMA 237:879-881, 1977.
10. Talley RB, Laventurier MF: Drug-induced illness. JAMA 229:1043, 1974.
11. Feinstein AR: Clinical biostatistics XXVIII: The biostatistical problems of pharmacologic surveillance. Clin Pharmacol Ther 16:110-123, 1974.
12. Karch FE, Smith CL, Kerzner B, et al: Adverse drug reactions—a matter of opinion. Clin Pharmacol Ther 19:489-492, 1976.
13. Koch-Weser J, Sellers EM, Zacest R: The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 11:75-78, 1977.
14. Irey NS: Diagnostic Problems and Methods in Drug-Induced Disease. American Registry of Pathology, Armed Forces Institute of Pathology, pt 1, 1966
15. pt 2, 1967
16. pt 3, 1968.
17. Karch FE, Lasagna L: Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 21:247-254, 1977.
18. Melmon KL: Preventable drug reactions— causes and cures. N Engl J Med 284:1361-1368, 1971.
19. Karch FE, Lasagna L: Adverse drug reactions: A critical review. JAMA 234:1236-1241, 1975.
20. Koch-Weser J, Sidel VN, Sweet RH, et al: Factors determining physician reporting of adverse drug reactions: Comparison of 2,000 spontaneous reports with surveillance studies at the Massachusetts General Hospital. N Engl J Med 280:20-26, 1969.
21. Bennett BS, Lipman AG: Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. Am J Hosp Pharm 34:931-936, 1977.
22. Borda IT, Slone D, Jick H: Assessment of adverse reactions within a drug surveillance program. JAMA 205:645-647, 1968.